Brian J Belmont

Title: Brian J Belmont: Innovator in Antibody and Cell Therapy Technologies

Introduction

Brian J Belmont is a prominent inventor based in Seattle, WA, known for his significant contributions to the fields of antibody and cell therapy technologies. With a total of eight patents to his name, Belmont has made remarkable advancements that have the potential to impact medical treatments significantly.

Latest Patents

Belmont's latest patents include groundbreaking work on antibodies and chimeric antigen receptors specific for receptor tyrosine kinase-like orphan receptor 1 (ROR1). This patent provides receptor tyrosine kinase-like orphan receptor 1 (ROR1)-binding molecules, particularly human antibodies specific for ROR1, including antibody fragments. The disclosure further relates to recombinant receptors, including chimeric antigen receptors (CARs) that contain such antibodies or fragments, and polynucleotides that encode the antibodies, antigen-binding fragments, or receptors specific for ROR1. Additionally, Belmont has developed HPV-specific binding molecules, which include TCRs or antigen-binding fragments and antibodies that recognize or bind human papillomavirus (HPV) 16, including HPV 16 E6 and HPV 16 E7. This patent also encompasses engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment involving the administration of these binding molecules, engineered cells, or compositions.

Career Highlights

Throughout his career, Belmont has worked with notable companies such as Abvitro LLC and Juno Therapeutics GmbH. His work in these organizations has allowed him to further his research and development in innovative therapeutic solutions.

Collaborations

Belmont has collaborated with esteemed colleagues, including Stephen Jacob Goldfless and Francois Vigneault, contributing to a rich exchange of ideas and advancements in their respective fields.

Conclusion

Brian J Belmont's innovative work in antibody and cell therapy technologies showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving treatment options for various diseases.